Therefore, roxadustat can lead to central hypothyroidism by inhibiting the release of thyroid-stimulating hormone (TSH) from the pituitary gland and/or thyrotropin-releasing hormone from the hypothalamus. The gene discussed is TRH; the disease is Central hypothyroidism.